Laboratory Corporation of America Holdings (LH) revenue breakdown
By segment, Diagnostics is the largest at 78% of fiscal 2025 revenue.
By region, North America is the largest at 81% of fiscal 2021 revenue; Europe grew fastest, 36% a year over 1 years.
Revenue by segment
Fiscal years, as Laboratory Corporation of America Holdings reports them in its 10-K filings; fiscal 2025 total $14.0B.
| Segments | 2016 | 2017 | 2018 | 2025 | Share |
|---|---|---|---|---|---|
| Diagnostics | — | — | — | $10.9B | 78% |
| Biopharma Laboratory Services | — | — | — | $3.1B | 22% |
| LabCorp Diagnostics | $6.3B | $6.9B | $7.0B | — | — |
| Covance Drug Development | $3.2B | $3.5B | $4.3B | — | — |
Revenue by region
Fiscal years, as Laboratory Corporation of America Holdings reports them in its 10-K filings; fiscal 2021 total $16.1B.
| Regions | 2018 | 2019 | 2020 | 2021 | Share |
|---|---|---|---|---|---|
| North America | — | — | $11.5B | $13.1B | 81% |
| Europe | — | — | $1.5B | $2.1B | 13% |
| Other countries | $1.2B | $1.2B | $941M | $976M | 6% |
| UNITED STATES | $8.8B | $9.0B | — | — | — |
| SWITZERLAND | $527M | $533M | — | — | — |
| UNITED KINGDOM | $439M | $508M | — | — | — |
| CANADA | $342M | $333M | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for LH.
Open LH in InvestinglyQuestions
Where does Laboratory Corporation of America Holdings make its money?
In fiscal 2025, by segment: Diagnostics $10.9B, Biopharma Laboratory Services $3.1B.
From Laboratory Corporation of America Holdings's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.